Inventor · disambiguated record
Tayeba Khan
Also filed as: KHAN TAYEBA
6 granted patents·3 pending applications·8 citations·filing 2014–2025
75Inventor score
Top patents by PatentIndex Score
9 records- 0187US10729787B2Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2018·Granted Aug 4, 2020·2 cites·12 claims
- 0283US10493135B2Methods of treating tissue calcificationALEXION PHARMA INC·Filed 2015·Granted Dec 3, 2019·4 cites·20 claims
- 0379US2023144623A1Systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0476US10004814B2Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2014·Granted Jun 26, 2018·2 cites·14 claims
- 0574US2025019677A1Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (npp1)INOZYME PHARMA INC·Filed 2024·Application pending·0 cites
- 0672US11529428B2Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·0 cites·16 claims
- 0772US2025312490A1Systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0860US12134790B2Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)INOZYME PHARMA INC·Filed 2018·Granted Nov 5, 2024·0 cites·25 claims
- 0946USRE49529EMethods of treating tissue calcificationINOZYME PHARMA INC·Filed 2015·Granted May 16, 2023·0 cites·29 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →